Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Medlab Asia & Asia Hea...Medlab Asia & Asia Health
Not Confirmed
Not Confirmed
24 November-17 July, 2025
Not Confirmed
Not Confirmed
26-27 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Medlab Asia & Asia Hea...Medlab Asia & Asia Health
Industry Trade Show
Not Confirmed
24 November-17 July, 2025
Industry Trade Show
Not Confirmed
26-27 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
21 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inxmed-fak-inhibitor-ifebemtinib-received-breakthrough-therapy-designation-by-china-national-medical-products-administration-for-first-line-non-small-cell-lung-cancer-nsclc-with-kras-g12c-mutation-302312546.html
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inxmed-presents-data-regarding-potential-novel-way-to-improve-therapeutic-window-of-adc-by-ifebemtinib-and-fic-adc-at-15th-annual-world-adc-302299542.html
30 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inxmed-reports-positive-phase-ibii-results-for-ifebemtinib-in-combination-with-garsorasib-in-non-small-cell-lung-cancer-nsclc-with-kras-g12c-mutation-302157162.html
19 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inxmed-enters-license-agreement-with-escugen-to-develop-next-generation-adcs-302019573.html
22 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inxmed-releases-data-demonstrating-ifebemtinib-in10018-trending-toward-survival-benefit-at-esmo-2023-301963834.html
18 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inxmed-presents-new-data-at-14th-annual-world-adc-highlighting-synergy-of-in10018-with-adcs-and-novel-stroma-targeting-pipeline-301960551.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?